Results - Announcements
Unichem Laboratories Ltd share price declined by 0.06% to Rs 504.05 after the company's net profit witnessed a sharp fall of 46.42% to Rs 22.22 crore, while revenue from operations slightly gained 1.20% to Rs 640.22 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, rising 5.14%. It has inched up 2.03% over last one week and moved up slightly by 1.77% in last one month while the market capitalization of Unichem Laboratories Ltd has softened by 0.04% and 3.25% in the same period respectively.
Profit before tax (PBT) of Unichem Laboratories Ltd stood at Rs 27.37 crore in Q3 FY26, nosediving by 352.96% year-on-year, and crashing by 44.13% quarter-on-quarter. EBITDA came in at Rs 59 crore, surging by 30.70% YoY and gaining 8.76% sequentially.
Total expenses grew marginally by 0.61% to Rs 596.25 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 255.11 crore, jumping 34.25% YoY, while employee benefits expense was at Rs 105.57 crore, inching up 2.19% YoY.
For the TTM ended FY26, revenue from operations posted a slight growth of 4.31% to Rs 2201.85 crore, while net profit soared by 83.86% to Rs 252.84 crore, compared to previous TTM. EBITDA jumped by 22910% to Rs 121.11 crore, and PBT jumped 89.13% to Rs 292.38 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 3.64 crore in FY26, as against Rs 7.02 crore in FY25.
Unichem Laboratories Ltd headed higher 7.14% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 7.38% during the same period.